ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Injectable Fertility Medications Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-32K16517
Home | Market Reports | Health| Reproductive Health
Global Injectable Fertility Medications Market Research Report 2024
BUY CHAPTERS

Global Injectable Fertility Medications Market Research Report 2025

Code: QYRE-Auto-32K16517
Report
September 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
LIVZON
GenSci
Novarel (Ferring)
Ovidrel (Merck)
Synarel (Pfizer Medical)
Profasi (Serum Institute Of India)

Injectable Fertility Medications Market

The global market for Injectable Fertility Medications was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Injectable fertility medications are pharmaceutical drugs administered through injections to assist individuals or couples in overcoming fertility challenges. These medications, often used in assisted reproductive technologies like in vitro fertilization (IVF), aim to stimulate the ovaries to produce multiple eggs or regulate the reproductive cycle. Injectable fertility drugs commonly include gonadotropins, such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH), as well as human chorionic gonadotropin (hCG). These medications play a crucial role in controlling and optimizing the reproductive process, enhancing the chances of successful conception for individuals facing fertility issues.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Injectable Fertility Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Fertility Medications.
The Injectable Fertility Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Fertility Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Fertility Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Injectable Fertility Medications Market Report

Report Metric Details
Report Name Injectable Fertility Medications Market
Segment by Type
  • Follicle Stimulating Hormone (FSH)
  • Luteinizing Hormone (LH)
  • Human Chorionic Gonadotropin (hCG)
  • Others
Segment by Application
  • IVF and Embryo Transfer
  • Infertility Treatment
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Novarel (Ferring), Ovidrel (Merck), Synarel (Pfizer Medical), Follitrope (LG Chem), Profasi (Serum Institute Of India), Livzon, GenSci
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Injectable Fertility Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Injectable Fertility Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Injectable Fertility Medications Market report?

Ans: The main players in the Injectable Fertility Medications Market are Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Novarel (Ferring), Ovidrel (Merck), Synarel (Pfizer Medical), Follitrope (LG Chem), Profasi (Serum Institute Of India), Livzon, GenSci

What are the Application segmentation covered in the Injectable Fertility Medications Market report?

Ans: The Applications covered in the Injectable Fertility Medications Market report are IVF and Embryo Transfer, Infertility Treatment

What are the Type segmentation covered in the Injectable Fertility Medications Market report?

Ans: The Types covered in the Injectable Fertility Medications Market report are Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), Human Chorionic Gonadotropin (hCG), Others

1 Injectable Fertility Medications Market Overview
1.1 Product Definition
1.2 Injectable Fertility Medications by Type
1.2.1 Global Injectable Fertility Medications Market Value Comparison by Type (2024 VS 2031)
1.2.2 Follicle Stimulating Hormone (FSH)
1.2.3 Luteinizing Hormone (LH)
1.2.4 Human Chorionic Gonadotropin (hCG)
1.2.5 Others
1.3 Injectable Fertility Medications by Application
1.3.1 Global Injectable Fertility Medications Market Value by Application (2024 VS 2031)
1.3.2 IVF and Embryo Transfer
1.3.3 Infertility Treatment
1.4 Global Injectable Fertility Medications Market Size Estimates and Forecasts
1.4.1 Global Injectable Fertility Medications Revenue 2020-2031
1.4.2 Global Injectable Fertility Medications Sales 2020-2031
1.4.3 Global Injectable Fertility Medications Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Injectable Fertility Medications Market Competition by Manufacturers
2.1 Global Injectable Fertility Medications Sales Market Share by Manufacturers (2020-2025)
2.2 Global Injectable Fertility Medications Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Injectable Fertility Medications Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Injectable Fertility Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Fertility Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Fertility Medications, Product Type & Application
2.7 Global Key Manufacturers of Injectable Fertility Medications, Date of Enter into This Industry
2.8 Global Injectable Fertility Medications Market Competitive Situation and Trends
2.8.1 Global Injectable Fertility Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Injectable Fertility Medications Players Market Share by Revenue
2.8.3 Global Injectable Fertility Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injectable Fertility Medications Market Scenario by Region
3.1 Global Injectable Fertility Medications Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Injectable Fertility Medications Sales by Region: 2020-2031
3.2.1 Global Injectable Fertility Medications Sales by Region: 2020-2025
3.2.2 Global Injectable Fertility Medications Sales by Region: 2026-2031
3.3 Global Injectable Fertility Medications Revenue by Region: 2020-2031
3.3.1 Global Injectable Fertility Medications Revenue by Region: 2020-2025
3.3.2 Global Injectable Fertility Medications Revenue by Region: 2026-2031
3.4 North America Injectable Fertility Medications Market Facts & Figures by Country
3.4.1 North America Injectable Fertility Medications Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Injectable Fertility Medications Sales by Country (2020-2031)
3.4.3 North America Injectable Fertility Medications Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Fertility Medications Market Facts & Figures by Country
3.5.1 Europe Injectable Fertility Medications Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Injectable Fertility Medications Sales by Country (2020-2031)
3.5.3 Europe Injectable Fertility Medications Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Fertility Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Injectable Fertility Medications Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Injectable Fertility Medications Sales by Region (2020-2031)
3.6.3 Asia Pacific Injectable Fertility Medications Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injectable Fertility Medications Market Facts & Figures by Country
3.7.1 Latin America Injectable Fertility Medications Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Injectable Fertility Medications Sales by Country (2020-2031)
3.7.3 Latin America Injectable Fertility Medications Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Fertility Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Fertility Medications Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Injectable Fertility Medications Sales by Country (2020-2031)
3.8.3 Middle East and Africa Injectable Fertility Medications Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Fertility Medications Sales by Type (2020-2031)
4.1.1 Global Injectable Fertility Medications Sales by Type (2020-2025)
4.1.2 Global Injectable Fertility Medications Sales by Type (2026-2031)
4.1.3 Global Injectable Fertility Medications Sales Market Share by Type (2020-2031)
4.2 Global Injectable Fertility Medications Revenue by Type (2020-2031)
4.2.1 Global Injectable Fertility Medications Revenue by Type (2020-2025)
4.2.2 Global Injectable Fertility Medications Revenue by Type (2026-2031)
4.2.3 Global Injectable Fertility Medications Revenue Market Share by Type (2020-2031)
4.3 Global Injectable Fertility Medications Price by Type (2020-2031)
5 Segment by Application
5.1 Global Injectable Fertility Medications Sales by Application (2020-2031)
5.1.1 Global Injectable Fertility Medications Sales by Application (2020-2025)
5.1.2 Global Injectable Fertility Medications Sales by Application (2026-2031)
5.1.3 Global Injectable Fertility Medications Sales Market Share by Application (2020-2031)
5.2 Global Injectable Fertility Medications Revenue by Application (2020-2031)
5.2.1 Global Injectable Fertility Medications Revenue by Application (2020-2025)
5.2.2 Global Injectable Fertility Medications Revenue by Application (2026-2031)
5.2.3 Global Injectable Fertility Medications Revenue Market Share by Application (2020-2031)
5.3 Global Injectable Fertility Medications Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gonal-F (Merck)
6.1.1 Gonal-F (Merck) Company Information
6.1.2 Gonal-F (Merck) Description and Business Overview
6.1.3 Gonal-F (Merck) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gonal-F (Merck) Injectable Fertility Medications Product Portfolio
6.1.5 Gonal-F (Merck) Recent Developments/Updates
6.2 Follistim (Organon)
6.2.1 Follistim (Organon) Company Information
6.2.2 Follistim (Organon) Description and Business Overview
6.2.3 Follistim (Organon) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Follistim (Organon) Injectable Fertility Medications Product Portfolio
6.2.5 Follistim (Organon) Recent Developments/Updates
6.3 Bravelle (Ferring)
6.3.1 Bravelle (Ferring) Company Information
6.3.2 Bravelle (Ferring) Description and Business Overview
6.3.3 Bravelle (Ferring) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bravelle (Ferring) Injectable Fertility Medications Product Portfolio
6.3.5 Bravelle (Ferring) Recent Developments/Updates
6.4 Menopur (Ferring)
6.4.1 Menopur (Ferring) Company Information
6.4.2 Menopur (Ferring) Description and Business Overview
6.4.3 Menopur (Ferring) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Menopur (Ferring) Injectable Fertility Medications Product Portfolio
6.4.5 Menopur (Ferring) Recent Developments/Updates
6.5 Fostimon (IBSA)
6.5.1 Fostimon (IBSA) Company Information
6.5.2 Fostimon (IBSA) Description and Business Overview
6.5.3 Fostimon (IBSA) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fostimon (IBSA) Injectable Fertility Medications Product Portfolio
6.5.5 Fostimon (IBSA) Recent Developments/Updates
6.6 Puregon (Organon)
6.6.1 Puregon (Organon) Company Information
6.6.2 Puregon (Organon) Description and Business Overview
6.6.3 Puregon (Organon) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Puregon (Organon) Injectable Fertility Medications Product Portfolio
6.6.5 Puregon (Organon) Recent Developments/Updates
6.7 BEMFOLA (Gedeon Richter)
6.7.1 BEMFOLA (Gedeon Richter) Company Information
6.7.2 BEMFOLA (Gedeon Richter) Description and Business Overview
6.7.3 BEMFOLA (Gedeon Richter) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BEMFOLA (Gedeon Richter) Injectable Fertility Medications Product Portfolio
6.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
6.8 Novarel (Ferring)
6.8.1 Novarel (Ferring) Company Information
6.8.2 Novarel (Ferring) Description and Business Overview
6.8.3 Novarel (Ferring) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novarel (Ferring) Injectable Fertility Medications Product Portfolio
6.8.5 Novarel (Ferring) Recent Developments/Updates
6.9 Ovidrel (Merck)
6.9.1 Ovidrel (Merck) Company Information
6.9.2 Ovidrel (Merck) Description and Business Overview
6.9.3 Ovidrel (Merck) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ovidrel (Merck) Injectable Fertility Medications Product Portfolio
6.9.5 Ovidrel (Merck) Recent Developments/Updates
6.10 Synarel (Pfizer Medical)
6.10.1 Synarel (Pfizer Medical) Company Information
6.10.2 Synarel (Pfizer Medical) Description and Business Overview
6.10.3 Synarel (Pfizer Medical) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Synarel (Pfizer Medical) Injectable Fertility Medications Product Portfolio
6.10.5 Synarel (Pfizer Medical) Recent Developments/Updates
6.11 Follitrope (LG Chem)
6.11.1 Follitrope (LG Chem) Company Information
6.11.2 Follitrope (LG Chem) Description and Business Overview
6.11.3 Follitrope (LG Chem) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Follitrope (LG Chem) Injectable Fertility Medications Product Portfolio
6.11.5 Follitrope (LG Chem) Recent Developments/Updates
6.12 Profasi (Serum Institute Of India)
6.12.1 Profasi (Serum Institute Of India) Company Information
6.12.2 Profasi (Serum Institute Of India) Description and Business Overview
6.12.3 Profasi (Serum Institute Of India) Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Profasi (Serum Institute Of India) Injectable Fertility Medications Product Portfolio
6.12.5 Profasi (Serum Institute Of India) Recent Developments/Updates
6.13 Livzon
6.13.1 Livzon Company Information
6.13.2 Livzon Description and Business Overview
6.13.3 Livzon Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Livzon Injectable Fertility Medications Product Portfolio
6.13.5 Livzon Recent Developments/Updates
6.14 GenSci
6.14.1 GenSci Company Information
6.14.2 GenSci Description and Business Overview
6.14.3 GenSci Injectable Fertility Medications Sales, Revenue and Gross Margin (2020-2025)
6.14.4 GenSci Injectable Fertility Medications Product Portfolio
6.14.5 GenSci Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Fertility Medications Industry Chain Analysis
7.2 Injectable Fertility Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Fertility Medications Production Mode & Process Analysis
7.4 Injectable Fertility Medications Sales and Marketing
7.4.1 Injectable Fertility Medications Sales Channels
7.4.2 Injectable Fertility Medications Distributors
7.5 Injectable Fertility Medications Customer Analysis
8 Injectable Fertility Medications Market Dynamics
8.1 Injectable Fertility Medications Industry Trends
8.2 Injectable Fertility Medications Market Drivers
8.3 Injectable Fertility Medications Market Challenges
8.4 Injectable Fertility Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
LIVZON
GenSci
Novarel (Ferring)
Ovidrel (Merck)
Synarel (Pfizer Medical)
Profasi (Serum Institute Of India)
List of Tables
 Table 1. Global Injectable Fertility Medications Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Injectable Fertility Medications Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Injectable Fertility Medications Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Injectable Fertility Medications Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Injectable Fertility Medications Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Injectable Fertility Medications Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Injectable Fertility Medications Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Injectable Fertility Medications Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Injectable Fertility Medications, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Injectable Fertility Medications, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Injectable Fertility Medications, Product Type & Application
 Table 12. Global Key Manufacturers of Injectable Fertility Medications, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Injectable Fertility Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Fertility Medications as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Injectable Fertility Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Injectable Fertility Medications Sales by Region (2020-2025) & (K Units)
 Table 18. Global Injectable Fertility Medications Sales Market Share by Region (2020-2025)
 Table 19. Global Injectable Fertility Medications Sales by Region (2026-2031) & (K Units)
 Table 20. Global Injectable Fertility Medications Sales Market Share by Region (2026-2031)
 Table 21. Global Injectable Fertility Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Injectable Fertility Medications Revenue Market Share by Region (2020-2025)
 Table 23. Global Injectable Fertility Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Injectable Fertility Medications Revenue Market Share by Region (2026-2031)
 Table 25. North America Injectable Fertility Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Injectable Fertility Medications Sales by Country (2020-2025) & (K Units)
 Table 27. North America Injectable Fertility Medications Sales by Country (2026-2031) & (K Units)
 Table 28. North America Injectable Fertility Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Injectable Fertility Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Injectable Fertility Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Injectable Fertility Medications Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Injectable Fertility Medications Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Injectable Fertility Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Injectable Fertility Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Injectable Fertility Medications Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Injectable Fertility Medications Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Injectable Fertility Medications Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Injectable Fertility Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Injectable Fertility Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Injectable Fertility Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Injectable Fertility Medications Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Injectable Fertility Medications Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Injectable Fertility Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Injectable Fertility Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Injectable Fertility Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Injectable Fertility Medications Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Injectable Fertility Medications Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Injectable Fertility Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Injectable Fertility Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Injectable Fertility Medications Sales (K Units) by Type (2020-2025)
 Table 51. Global Injectable Fertility Medications Sales (K Units) by Type (2026-2031)
 Table 52. Global Injectable Fertility Medications Sales Market Share by Type (2020-2025)
 Table 53. Global Injectable Fertility Medications Sales Market Share by Type (2026-2031)
 Table 54. Global Injectable Fertility Medications Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Injectable Fertility Medications Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Injectable Fertility Medications Revenue Market Share by Type (2020-2025)
 Table 57. Global Injectable Fertility Medications Revenue Market Share by Type (2026-2031)
 Table 58. Global Injectable Fertility Medications Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Injectable Fertility Medications Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Injectable Fertility Medications Sales (K Units) by Application (2020-2025)
 Table 61. Global Injectable Fertility Medications Sales (K Units) by Application (2026-2031)
 Table 62. Global Injectable Fertility Medications Sales Market Share by Application (2020-2025)
 Table 63. Global Injectable Fertility Medications Sales Market Share by Application (2026-2031)
 Table 64. Global Injectable Fertility Medications Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Injectable Fertility Medications Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Injectable Fertility Medications Revenue Market Share by Application (2020-2025)
 Table 67. Global Injectable Fertility Medications Revenue Market Share by Application (2026-2031)
 Table 68. Global Injectable Fertility Medications Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Injectable Fertility Medications Price (US$/Unit) by Application (2026-2031)
 Table 70. Gonal-F (Merck) Company Information
 Table 71. Gonal-F (Merck) Description and Business Overview
 Table 72. Gonal-F (Merck) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Gonal-F (Merck) Injectable Fertility Medications Product
 Table 74. Gonal-F (Merck) Recent Developments/Updates
 Table 75. Follistim (Organon) Company Information
 Table 76. Follistim (Organon) Description and Business Overview
 Table 77. Follistim (Organon) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Follistim (Organon) Injectable Fertility Medications Product
 Table 79. Follistim (Organon) Recent Developments/Updates
 Table 80. Bravelle (Ferring) Company Information
 Table 81. Bravelle (Ferring) Description and Business Overview
 Table 82. Bravelle (Ferring) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bravelle (Ferring) Injectable Fertility Medications Product
 Table 84. Bravelle (Ferring) Recent Developments/Updates
 Table 85. Menopur (Ferring) Company Information
 Table 86. Menopur (Ferring) Description and Business Overview
 Table 87. Menopur (Ferring) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Menopur (Ferring) Injectable Fertility Medications Product
 Table 89. Menopur (Ferring) Recent Developments/Updates
 Table 90. Fostimon (IBSA) Company Information
 Table 91. Fostimon (IBSA) Description and Business Overview
 Table 92. Fostimon (IBSA) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Fostimon (IBSA) Injectable Fertility Medications Product
 Table 94. Fostimon (IBSA) Recent Developments/Updates
 Table 95. Puregon (Organon) Company Information
 Table 96. Puregon (Organon) Description and Business Overview
 Table 97. Puregon (Organon) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Puregon (Organon) Injectable Fertility Medications Product
 Table 99. Puregon (Organon) Recent Developments/Updates
 Table 100. BEMFOLA (Gedeon Richter) Company Information
 Table 101. BEMFOLA (Gedeon Richter) Description and Business Overview
 Table 102. BEMFOLA (Gedeon Richter) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BEMFOLA (Gedeon Richter) Injectable Fertility Medications Product
 Table 104. BEMFOLA (Gedeon Richter) Recent Developments/Updates
 Table 105. Novarel (Ferring) Company Information
 Table 106. Novarel (Ferring) Description and Business Overview
 Table 107. Novarel (Ferring) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Novarel (Ferring) Injectable Fertility Medications Product
 Table 109. Novarel (Ferring) Recent Developments/Updates
 Table 110. Ovidrel (Merck) Company Information
 Table 111. Ovidrel (Merck) Description and Business Overview
 Table 112. Ovidrel (Merck) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Ovidrel (Merck) Injectable Fertility Medications Product
 Table 114. Ovidrel (Merck) Recent Developments/Updates
 Table 115. Synarel (Pfizer Medical) Company Information
 Table 116. Synarel (Pfizer Medical) Description and Business Overview
 Table 117. Synarel (Pfizer Medical) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Synarel (Pfizer Medical) Injectable Fertility Medications Product
 Table 119. Synarel (Pfizer Medical) Recent Developments/Updates
 Table 120. Follitrope (LG Chem) Company Information
 Table 121. Follitrope (LG Chem) Description and Business Overview
 Table 122. Follitrope (LG Chem) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Follitrope (LG Chem) Injectable Fertility Medications Product
 Table 124. Follitrope (LG Chem) Recent Developments/Updates
 Table 125. Profasi (Serum Institute Of India) Company Information
 Table 126. Profasi (Serum Institute Of India) Description and Business Overview
 Table 127. Profasi (Serum Institute Of India) Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Profasi (Serum Institute Of India) Injectable Fertility Medications Product
 Table 129. Profasi (Serum Institute Of India) Recent Developments/Updates
 Table 130. Livzon Company Information
 Table 131. Livzon Description and Business Overview
 Table 132. Livzon Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Livzon Injectable Fertility Medications Product
 Table 134. Livzon Recent Developments/Updates
 Table 135. GenSci Company Information
 Table 136. GenSci Description and Business Overview
 Table 137. GenSci Injectable Fertility Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. GenSci Injectable Fertility Medications Product
 Table 139. GenSci Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Injectable Fertility Medications Distributors List
 Table 143. Injectable Fertility Medications Customers List
 Table 144. Injectable Fertility Medications Market Trends
 Table 145. Injectable Fertility Medications Market Drivers
 Table 146. Injectable Fertility Medications Market Challenges
 Table 147. Injectable Fertility Medications Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Injectable Fertility Medications
 Figure 2. Global Injectable Fertility Medications Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Injectable Fertility Medications Market Share by Type: 2024 & 2031
 Figure 4. Follicle Stimulating Hormone (FSH) Product Picture
 Figure 5. Luteinizing Hormone (LH) Product Picture
 Figure 6. Human Chorionic Gonadotropin (hCG) Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Injectable Fertility Medications Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Injectable Fertility Medications Market Share by Application: 2024 & 2031
 Figure 10. IVF and Embryo Transfer
 Figure 11. Infertility Treatment
 Figure 12. Global Injectable Fertility Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Injectable Fertility Medications Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Injectable Fertility Medications Sales (2020-2031) & (K Units)
 Figure 15. Global Injectable Fertility Medications Average Price (US$/Unit) & (2020-2031)
 Figure 16. Injectable Fertility Medications Report Years Considered
 Figure 17. Injectable Fertility Medications Sales Share by Manufacturers in 2024
 Figure 18. Global Injectable Fertility Medications Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Injectable Fertility Medications Players: Market Share by Revenue in Injectable Fertility Medications in 2024
 Figure 20. Injectable Fertility Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Injectable Fertility Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Injectable Fertility Medications Sales Market Share by Country (2020-2031)
 Figure 23. North America Injectable Fertility Medications Revenue Market Share by Country (2020-2031)
 Figure 24. United States Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Injectable Fertility Medications Sales Market Share by Country (2020-2031)
 Figure 27. Europe Injectable Fertility Medications Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Injectable Fertility Medications Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Injectable Fertility Medications Revenue Market Share by Region (2020-2031)
 Figure 35. China Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Injectable Fertility Medications Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Injectable Fertility Medications Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Injectable Fertility Medications Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Injectable Fertility Medications Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Injectable Fertility Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Injectable Fertility Medications by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Injectable Fertility Medications by Type (2020-2031)
 Figure 54. Global Injectable Fertility Medications Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Injectable Fertility Medications by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Injectable Fertility Medications by Application (2020-2031)
 Figure 57. Global Injectable Fertility Medications Price (US$/Unit) by Application (2020-2031)
 Figure 58. Injectable Fertility Medications Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Injectable IVF Medications Market Research Report 2024
Global Infertility Treatment Drugs Market Insights Forecast to 2030
Global Fertility Drugs Market Insights Forecast to 2030
Global Fertility Enhancing Treatment Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024
Global Recombinant FSH Injections Market Research Report 2024
Global Infertility Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Female Infertility Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Assisted Reproductive Medications Market Research Report 2024
Assisted Reproductive Technologies Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non injectable GnRH Drugs Market Research Report 2024
Assisted Reproductive Technologies Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproductive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Fertilization IVF Treatment Market
Global Assisted Reproductive Treatment Market Research Report 2024
Global Pregnancy and Fertility Testing Kits Market Insights Forecast to 2030
Global Injectable Thyroid Drug Market Research Report 2024
Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2024
Global IVF Software Market Insights Forecast to 2030
Global IVF Service Market Research Report 2024

RELATED REPORTS

Global Foetal Skull Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8G20187
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Anatomy Set Pregnancy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30J19782
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Embryo Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39D19945
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Prostate Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25M19897
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions